Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
176 | Advances in Pharmacological Sciences | journal | 0.862 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
175 | Alcoholism: Clinical and Experimental Research | journal | 1.050 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
174 | Journal of Caffeine and Adenosine Research | journal | 1 | 8 | 0 | 266 | 0 | 0 | 0.00 | 33.25 | ||
173 | NTP Research Report Series | book series | 3 | 1 | 13 | 52 | 3 | 13 | 0.00 | 52.00 | ||
172 | Contract Pharma | trade journal | 0.101 Q4 | 4 | 0 | 41 | 0 | 0 | 41 | 0.00 | 0.00 | |
171 | Pharmaceutical Processing | trade journal | 0.107 Q4 | 4 | 0 | 12 | 0 | 0 | 4 | 0.00 | 0.00 | |
170 | WikiJournal of Medicine | journal | 0.214 Q3 | 4 | 4 | 14 | 331 | 13 | 14 | 0.93 | 82.75 | |
169 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 4 | 7 | 490 | 1 | 7 | 0.20 | 122.50 | ||
168 | Precision Nanomedicine | journal | 6 | 12 | 32 | 664 | 38 | 29 | 1.19 | 55.33 | ||
167 | Pharmaceutical Outsourcing | journal | 0.101 Q4 | 7 | 15 | 38 | 34 | 0 | 34 | 0.00 | 2.27 | |
166 | Adverse Drug Reaction Bulletin | journal | 0.124 Q4 | 8 | 6 | 18 | 185 | 8 | 17 | 0.58 | 30.83 | |
165 | Drug Topics | journal | 0.101 Q4 | 8 | 133 | 508 | 11 | 8 | 42 | 0.02 | 0.08 | |
164 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 91 | 549 | 496 | 5 | 234 | 0.01 | 5.45 | |
163 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 3 | 5 | 524 | 2 | 5 | 0.00 | 174.67 | ||
162 | ACS Bio and Med Chem Au | journal | 11 | 7 | 0 | 279 | 0 | 0 | 0.00 | 39.86 | ||
161 | Drug Development and Delivery | trade journal | 0.127 Q4 | 12 | 64 | 203 | 335 | 7 | 107 | 0.04 | 5.23 | |
160 | U.S. Pharmacist | trade journal | 0.130 Q4 | 12 | 117 | 377 | 1193 | 78 | 246 | 0.18 | 10.20 | |
159 | International Journal of Pharmaceutical Compounding | journal | 0.126 Q4 | 13 | 68 | 206 | 0 | 74 | 183 | 0.38 | 0.00 | |
158 | Applied In Vitro Toxicology | journal | 0.458 Q3 | 15 | 19 | 69 | 905 | 165 | 59 | 1.12 | 47.63 | |
157 | American Journal of Pharmacy Benefits | journal | 0.339 Q2 | 16 | 0 | 6 | 0 | 4 | 4 | 0.00 | 0.00 | |
156 | Journal of Pharmacy Technology | journal | 0.177 Q3 | 16 | 44 | 110 | 1177 | 66 | 96 | 0.63 | 26.75 | |
155 | Journal of Excipients and Food Chemicals | journal | 0.182 Q3 | 17 | 11 | 31 | 284 | 22 | 18 | 0.47 | 25.82 | |
154 | Current Protocols | journal | 18 | 291 | 0 | 11491 | 0 | 0 | 0.00 | 39.49 | ||
153 | Pharmaceutical Engineering | journal | 0.104 Q4 | 18 | 0 | 14 | 0 | 0 | 7 | 0.00 | 0.00 | |
152 | JACCP Journal of the American College of Clinical Pharmacy | journal | 0.330 Q2 | 19 | 187 | 280 | 5697 | 365 | 221 | 1.31 | 30.47 | |
151 | Pharmaceutical Technology Europe | journal | 0.115 Q4 | 19 | 138 | 192 | 716 | 10 | 162 | 0.09 | 5.19 | |
150 | OpenNano | journal | 0.932 Q1 | 21 | 2 | 12 | 106 | 151 | 12 | 10.00 | 53.00 | |
149 | Medical Letter on Drugs and Therapeutics | journal | 0.254 Q4 | 22 | 114 | 311 | 806 | 171 | 207 | 0.71 | 7.07 | |
148 | National Toxicology Program technical report series | journal | 0.114 | 22 | 3 | 7 | 0 | 7 | 7 | 0.00 | 0.00 | |
147 | Neuropsychopharmacology Reports | journal | 0.579 Q2 | 22 | 65 | 129 | 2788 | 272 | 127 | 2.13 | 42.89 | |
146 | Food and Drug Law Journal | journal | 0.485 Q3 | 23 | 3 | 19 | 387 | 18 | 19 | 0.00 | 129.00 | |
145 | Mental Health Clinician | journal | 23 | 46 | 116 | 1120 | 223 | 114 | 1.51 | 24.35 | ||
144 | MedComm | journal | 25 | 51 | 38 | 6578 | 91 | 29 | 2.39 | 128.98 | ||
143 | American Pharmaceutical Review | journal | 0.114 Q4 | 26 | 0 | 170 | 0 | 29 | 151 | 0.17 | 0.00 | |
142 | Contemporary Clinical Trials Communications | journal | 0.748 Q2 | 26 | 171 | 465 | 7193 | 972 | 454 | 1.70 | 42.06 | |
141 | International Nano Letters | journal | 0.130 Q4 | 26 | 30 | 61 | 1876 | 355 | 61 | 5.82 | 62.53 | |
140 | Bioengineering and Translational Medicine | journal | 1.470 Q1 | 28 | 57 | 33 | 3764 | 236 | 25 | 7.15 | 66.04 | |
139 | Hospital Pharmacy | journal | 0.253 Q4 | 28 | 128 | 191 | 2723 | 201 | 157 | 1.16 | 21.27 | |
138 | Molecular and Cellular Pharmacology | journal | 28 | 1 | 2 | 0 | 0 | 0 | 0.00 | 0.00 | ||
137 | Value in Health Regional Issues | journal | 0.414 Q2 | 28 | 83 | 232 | 3325 | 372 | 224 | 1.57 | 40.06 | |
136 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.267 Q3 | 29 | 7 | 23 | 645 | 69 | 7 | 3.18 | 92.14 | |
135 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.370 Q4 | 31 | 0 | 52 | 0 | 78 | 52 | 1.23 | 0.00 | |
134 | Currents in Pharmacy Teaching and Learning | journal | 0.537 Q1 | 31 | 254 | 601 | 5452 | 1041 | 553 | 1.45 | 21.46 | |
133 | BioPharm International | trade journal | 0.106 Q4 | 32 | 23 | 342 | 110 | 27 | 97 | 0.09 | 4.78 | |
132 | Current Cardiovascular Risk Reports | journal | 0.424 Q3 | 34 | 22 | 94 | 1361 | 77 | 94 | 0.94 | 61.86 | |
131 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.256 Q3 | 34 | 26 | 101 | 856 | 133 | 101 | 1.19 | 32.92 | |
130 | Clinical Pharmacology in Drug Development | journal | 0.531 Q2 | 35 | 147 | 306 | 3752 | 640 | 292 | 2.23 | 25.52 | |
129 | Journal of Pharmaceutical Innovation | journal | 0.364 Q2 | 35 | 65 | 123 | 1997 | 279 | 118 | 2.24 | 30.72 | |
128 | ACS Pharmacology and Translational Science | journal | 1.673 Q1 | 36 | 170 | 196 | 10014 | 983 | 182 | 4.91 | 58.91 | |
127 | Cancer Nanotechnology | journal | 0.921 Q1 | 36 | 33 | 37 | 2004 | 295 | 35 | 7.46 | 60.73 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®